SIGA· Health Care› Drug Manufacturers - Specialty & Generic

SIGA Technologies Inc.

Stage 1 · Basing · week 14→1 today

As of Oct 22, 2026, SIGA Technologies is in Stage 1, the basing phase, now in its first week (since Oct 22, 2026). It closed at $3.15, 57.8% below its 52-week high and below its 200-day average, which is falling.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. More about the company

$3.15

+0.42% today

$226M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Steady

Edge

—

Is SIGA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 27w

S2 20w

S4 31w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 11w → S1 4w → S2 9w → S3 3w → S4 2w → S3 1w → S2 12w → S3 6w → S2 9w → S3 5w → S4 27w → S1 7w → S2 20w → S3 7w → S4 7w → S1 5w → S4 31w → S1 1w current

Total tracked: 165 weeks across 18 stage runs.

SIGA among Drug Manufacturers - Specialty & Generic61st of 84 by relative strength

All 84 →

Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	CPIXCumberland Pharmaceuticals Inc.	Stage 2 · wk 23	98	+6.8%
2	ETONEton Pharmaceuticals, Inc.	Stage 2 · wk 30	97	−10.1%
3	ANIKAnika Therapeutics Inc.	Stage 2 · wk 15	96	+3.5%
4	IRWDIronwood Pharmaceuticals, Inc. Class A	Stage 3 · wk 3	96	−16.4%
5	TEVATeva Pharmaceutical Industries Limited	Stage 2 · wk 9	95	+3.1%
6	AMRXAmneal Pharmaceuticals, Inc. Class A	Stage 2 · wk 19	95	+5.9%
7	KNSAKiniksa Pharmaceuticals International, plc Class A	Stage 2 · wk 73	95	+6.2%
8	AMLXAmylyx Pharmaceuticals, Inc.	Stage 2 · wk 15	93	−6.6%
…61	SIGASIGA Technologies Inc.	Stage 1 · wk 1	19	−0.6%

vs 52W High

-57.8%

$2.87 lo$7.47 hi

57.8% below 52W high

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 1

1w13w26w

Week 1, early base

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

-26.2%

200 DMA: $4.27 · sloping down

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.31x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

→

Short-term trend flat

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-0.6%

+1.3%

-30.5%

YTD

-43.2%

-58.0%

Scan Membership

Breakout Watch

Latest: 2025-06-23

11 appearances in last 60 days. First seen: 2019-01-25.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S14→1

Wk 1 · Vol 0.31x

2026-10-21S4

Wk 31 · Vol 0.32x

2026-10-20S4

Wk 31 · Vol 0.48x

2026-10-19S4

Wk 30 · Vol 0.59x

2026-10-16S4

Wk 30 · Vol 1.36x

2026-10-15S4

Wk 30 · Vol 1.07x

2026-10-14S4

Wk 30 · Vol 0.50x

2026-10-13S4

Wk 30 · Vol 0.44x

2026-10-12S4

Wk 29 · Vol 0.48x

2026-10-09S4

Wk 29 · Vol 0.69x

2026-10-08S4

Wk 29 · Vol 0.99x

2026-10-07S4

Wk 29 · Vol 0.61x

Moving averages & range

50 DMA

$3.16

200 DMA

$4.27

52W High

$7.47

52W Low

$2.87

5D Low

$3.14

Resistance levels (recent highs)

20d High

$3.48

60d High

$3.48

120d High

$4.80

250d High

$7.47

Next resistance

+10.5%

to 20d High

Earnings Growth (YoY)

-65.3%

Revenue -49.5%

ROE

-1.5%

Profit margin -5.2%

Dividend Yield

0.00%

P/B 1.4

SIGA Technologies: quick answers

What stage is SIGA Technologies in?

As of Oct 22, 2026, SIGA Technologies (SIGA) is in Stage 1, the basing phase. It entered Stage 1 on Oct 22, 2026 and is in its first week there. What the four stages mean

Is SIGA Technologies in an uptrend?

Not yet. SIGA Technologies is in Stage 1, a base that can come before an uptrend. It trades 26.2% below its 200-day average, which is falling.

How far is SIGA Technologies from its 52-week high?

SIGA Technologies closed at $3.15 on Oct 22, 2026, 57.8% below its 52-week high of $7.47. Its 52-week low is $2.87.

How has SIGA Technologies performed over the past year?

As of Oct 22, 2026, SIGA Technologies is down 58.0% over the past year and down 43.2% so far in 2026.

Which sector and industry is SIGA Technologies in?

SIGA Technologies is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.